4.6 Article

Metformin Do we finally have an anti-aging drug?

Journal

CELL CYCLE
Volume 12, Issue 22, Pages 3483-3489

Publisher

TAYLOR & FRANCIS INC
DOI: 10.4161/cc.26928

Keywords

diabetes; cancer; aging; gerosuppression; geroconversion

Categories

Funding

  1. Russian Federation [6538.2102.4]

Ask authors/readers for more resources

Studies in mammals have demonstrated that hyperglycemia and hyperinsulinemia are important factors in aging and cancer. Inactivation of insulin/insulin-like signaling increases lifespan in nematodes, fruit flies, and mice. Life-prolonging effects of caloric restriction are in part due to reduction in IGF-1, insulin, and glucose levels. Antidiabetic biguanides such as metformin, which reduce hyperglycemia and hyperinsulinemia by decreasing insulin resistance, extend lifespan, and inhibit carcinogenesis in rodents. Will antidiabetic biguanides increase lifespan in humans?

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available